HONLIV HEALTH (09906) · Company profile · Eqvero

HONLIV HEALTH

09906HKEX

Unit: CNY	FY2024	FY2023	FY2022	FY2021
Revenue	768.73 m CNY	760.53 m CNY	727.79 m CNY	606.84 m CNY
Cost of revenue	567.51 m CNY	555.45 m CNY	530.19 m CNY	437.82 m CNY
Selling, general and administrative expense	76.38 m CNY	72.39 m CNY	73.35 m CNY	68.55 m CNY
Operating profit after depreciation	49.14 m CNY	57.46 m CNY	66.03 m CNY	66.62 m CNY
Operating profit before depreciation	123.67 m CNY	117.7 m CNY	120.79 m CNY	100.33 m CNY
EBIT	49.14 m CNY	57.46 m CNY	66.03 m CNY	66.62 m CNY
EBITDA	123.67 m CNY	117.7 m CNY	120.79 m CNY	100.33 m CNY
Interest expense	8.58 m CNY	7.65 m CNY	9.35 m CNY	13.94 m CNY
Profit before tax	42.7 m CNY	51.42 m CNY	63.02 m CNY	50.54 m CNY
Income tax expense	11.22 m CNY	12.72 m CNY	13.68 m CNY	13.52 m CNY
Income before extraordinary items	31.15 m CNY	38.31 m CNY	48.95 m CNY	36.62 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.